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Introduction: Transient elastography is a rapid, noninvasive and reproduc-
ible approach to assess liver fibrosis by measuring liver stiffness (LS). How-
ever, because the liver is enveloped by a capsule, any variation in
parenchymal fluid content could theoretically affect LS. LS has been corre-
lated to central venous pressure (CVP) in an animal model. We aimed to
determine the correlation between LS and CVP in children and adults with
congenital heart disease.
Methods: In this ongoing prospective study, all patients referred for right
heart catheterization were included. Measurements of mean right atrial pres-
sure were obtained under general anesthesia (Fi02=21%) using an Optitorque
5 French catheter. The patients underwent 10 LS measurements (median value
taken as representive) by transient elastography (Fibroscanâ, Echosens,
France) within the 24 hours before catheterization. The results of LS are
expressed in kilopascals (kPa).
Results: Eleven children (mean age=8±6 yo, 54% male) and 6 adults
(mean age=34±17 yo, 66% male) have been included so far. Catheterism indi-
cations were pulmonary angioplasty (n=5), Melody valve implantation (n=1),
fenestration occlusion after a Fontan procedure (n=1) and pre operative asses-
sement of a complex congenital heart defect (n=10). Mean right atrial pressure
was 9,1±3,9 mmHg and mean LS was 8,4±4,2 kPa. Correlation between LS
and mean right atrial pressure was excellent for these first 17 patients (r=0,87).
Conclusion: Liver stiffness is a new, rapid and reliable method to evaluate
CVP in patients with congenital heart disease. This non invasive parameter
could potentially be usefull for patients in whom CVP play a key role, espe-
cially in patients with a Fontan circulation.
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Introduction: The use of COAGUCHEK XS® (Roche Diagnostics), an
INR home measuring device, was authorised by the French Health High
Authority on June 2008 for children. Nevertheless, there are few data on
safety and effectiveness of patients self management particularly in children.
Methods: Since 2008, 23 children (mean age: 9 y; 16 males, 7 females)
and their families were trained to INR self testing and self management of
vitamin K antagonists (VKA) (acenocoumarol: n=10, fluindione : n=9, war-
farin: n=4). INR controls (self testing or lab) were made at expected dates
established by the french law. Additional measurements were authorised in
risky situations (illness, hyperthermia, forgetting VKA treatment, bleeding,
etc…). Drug dose adaptation was made either by the family or by the health
team if needed.
Objectives: To evaluate safety and efficacy in families performing self
management in our centre. Time in therapeutic range (TTR), severe haemor-
rhage (needing hospitalization and/or blood transfusion) and thrombosis recur-
rence were observed.
Results: Mean follow-up time was 529 days [1.5 y; range 0.3-2.5y]. Mean
TTR was 68.53% and was 90.14% when tolerance range was applied. There
was no severe haemorrhage or thrombosis recurrence during follow-up and
INR >5 were 0.5% (8/1604 measurements). Lastly, 3.5% additional measure-
ments were performed by the families.
Conclusion: VKA self management using COAGUCHEK XS® was safe
and effective in our centre. Clinical studies with larger sample and cost-effec-
tiveness considerations are required.
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The objective of this study was to report experience with levosimendan in
hemodynamically compromised children.
Material and methods: all patients aged < 18years with severe myo-
cardial dysfunction and dependent on inotrope support, who received levosi-
mendan infusion, were reviewed for clinical, biological and echocardiographic
(LV diameters, shortening fraction, sub-aortic Velocity Time Integral) data.
Levosimendan was administered as a continuous intravenous infusion over
24 hours, starting 0.1 micrograms per kg per mn and increased up to
0.2micrograms per kg per mn. Blood pressure and heart rate were continu-
ously monitored, ECG and Echocardiography recorded before, 3 and 5 days
after starting levosimendan.
Results: From 2007 to 2011, 8 patients aged 3.5 months to 13years (mean
41months) received 10 courses of levosimendan. All were on milrinone sup-
port (mean dose 0.63 mcg/kg/mn) and 3 on associated dobutamine. All
achieved the 24-hour course of levosimendan without any complication. Cat-
echolamines were successfully discontinued in 5 cases (3 weaned off at 24th
hour and 2 at 5th day). Average milrinone dose dropped to 0.3 mcg/kg/mn at
day-5, p=0.028). mean shortening fraction increased from 10.8%±1.8 before
to 12.7± 2.3 at day-3 (p= 0.67), mean Velocity Time Integral from 6±0.6 to
8.7±1.2 cm at day-3 (p= 0.04). 
Five patients (62.5%) were successfully discharged from CICU: 2 are
doing well at 1 and 4.5 years follow-up, 1 died from metabolic disease and
2 were readmitted at 1.5 – and 2-month interval and received a second course
of levosimendan. The latter 2 patients did not improve and needed mechanical
ventricular assistance (1 died and 1 underwent successful heart transplanta-
tion). For the remaining 3 patients, first course levosimendan failed and heart
transplantation was performed in an emergency setting (pretransplant mechan-
ical ventricular support in 2).
Conclusion: This small size sample study shows encouraging results of
levosimendan in children with uncontrolled myocardial dysfunction. Further
studies are needed to assess monitoring, timing and indications for repeated
dose infusion during follow-up.
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Background: Congenital heart defects are often diagnosed in infancy, or
even before birth. But some anomalies are harder to detect than others and
may not be diagnosed until much later in childhood or even adulthood. In
developing countries many congenital heart diseases are detected in adult-
hood.
Objective: The aim of this study was to investigate the epidemiology, clin-
ical aspects, diagnosis and treatment of congenital heart disease screened at
adulthood.
Methods: This is a retrospective cohort by medical records analysis
enrolled between January 2010 and March 2012 in one center. We investi-
gated patients with congenital heart diseases aged over 16 years. All patients
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underwent a clinical examination, an echocardiogram, an oesophagial echocar-
diogram or other radiologic (CT or MRI), to specify the congenital heart dis-
ease. All patients had an adequate interventional cardiology, surgical care or
medical intervention.
Results: We included 44 patients, 23 cases of atial septal defects (ASD)
with mean age 38 years (16 women and 07 men), 8 ASD closed surgically and
15 by percutaneous routes.
4 patent ductus arteriosus: mean age 32 years (04 women), closed by per-
cutaneous.
4 cases coarctation of the aorta, mean age 32 years (4 women), dilated with
percutaneous procedure. 9 pulmonary stenosis, mean age: 30 years, all patients
underwent balloon dilation. We investigate also one bicuspid aortic with aortic
stenosis and 2 Epstein anomaly.
The outcome was favorable for all patients diagnosed during this period.
Conclusion: Congenital heart defects discovered in adulthood are not
uncommon and should be supported either by medical, surgical, or interven-
tional.
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Pulmonary arterial hypertension after successful arterial switch operation
(ASO) for simple transposition of the great arteries is a rare but important
cause of late morbidity and mortality. However this complication is poorly
characterised in the literature. In Here, we report the prevalence of this condi-
tion and its outcomes from the largest series of ASO procedures yet reported.
Methods: Between January 1985 and June 2011, 1137 arterial switch proce-
dures were performed for simple TGA at the Hôpital Necker Enfants Malades
in Paris. All patients underwent ASO within the early neonatal period. In all
cases, pulmonary pressure was evaluated at routine echocardiography and pul-
monary hypertension was confirmed by right heart catheterisation.
Results: Of 1137 consecutive ASO cases, 8 patients (0.7%, 95% confi-
dence interval 0.29-1.36%) developed severe PAH in the peri-operative period
that persisted beyond 1 month post-operatively requiring PAH targeted
therapy. Three of those resolved with treatment after 3, 4 and 5 months
respectively.
The prevalence of PAH in a general French paediatric population was esti-
mated to be 3.7 per million. These data suggest that long-term survivors of the
ASO have a relative risk for the development of PAH around 2000-fold (point
estimate 1757-fold, 95% confidence interval 785-3932) compared to children
without congenital heart disease.
Conclusion: Pulmonary hypertension is a severe complication of TGA
which must be rapidly detected in order to initiate targeted therapy. Revers-
ibility is indeed not excluded since last cases of our series have normalized
their pulmonary pressure.
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Many devices are available for atrial septal defect (ASD) usually in adults
and children. We report here one center experience in transcatheter closure of
ASD in infancy, using the Amplatzer septal occluder. From January 2003 to
March 2010, 10 males and 5 female, mean age 10.9±6.4 months, with weight
6.7±2.5 kg underwent transcatheter closure of atrial septal defect. The patients
had significant left-to-right shunting (n=12), right-to-left shunting with hypo-
xemia (n=3). For the left-to-right shunting, the ASD was closed for pulmonary
hypertension (n=10), for recurrent chest infection and bronchiolitis (n=5). The
ASD was associated with other congenital heart defect (n=5), prematurity and
bronchopulmonary dysplasia (n=6), foetopathy (n=1) and encephalopathy
(n=1).
The ASD was evaluated by transthoracic echocardiography (TEE) before
the procedure. Percutaneous closure was realized with TEE for all patients.
They received intravenous heparin. For 4 patients implantation was performed
after a balloon test occlusion (mean 11±3.4 mm diameter). The ASO device
size was 10.4±3.9 mm. The fluoroscopy time was 7.9±3.9 minutes and the
time of the procedure 55.6±21.8 minutes. No per procedural complications
were observed for all but for two (one anomalous device deployment and one
insufficient rim). These two patients were subsequently surgically repaired.
Patients left the hospital with a low dose of aspirin for 6 months.
During follow-up, four patients had a minimal residual shunt on TEE per-
formed up to one year after the implantation. No later cardiac complication
was observed.
To conclude, transcatheter closure of atrial septal defect in infant with the
ASO is feasible and a possible alternative to surgical closure. In addition,
ASD occlusion improves the respiratory status and reduces the level of pul-
monary hypertension. Additional long-term results and a large study are both
necessary to establish the future of this population
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Background: Precise features of infants with partial and transitional atrio-
ventricular septal (PAVC) defect requiring surgical repair remain undeter-
mined, as well as their outcome. We retrospectively analyzed this patient
population.
Patients and Method: Cases with single ventricle palliation were excluded.
Since January 1st, 2000, 11 infants (< 1 year of age) underwent surgical repair
of PAVC in our institution, at a median age and weight of 7 (2 to 11) months
and 6.2 (3.4 to 7.8) Kg, respectively. All patients had refractory congestive heart
failure before surgery. Six patients were prenatally diagnosed and 2 had Down
syndrome. Three patients had a small left atrioventricular valve (LAVV) with a
Z-score diameter < – 2. One infant had and associated aortic coarctation neces-
sitating concomitant repair. Other associated cardiac anomalies included persis-
tent left superior vena cava and interrupted inferior vena cava.
Results: All the patients survived after surgical repair, with a median stay
of 2 (1 to 21) days in the intensive care unit. One patient with a parachute
LAVV was reoperated 1 month after surgery for LAVV insufficiency. After a
median follow-up of 4,56 (2,6 to 12,2) years, all the patients are in NYHA
class I, with no medication. Echocardiography shows moderate LAVV insuf-
ficiency in 2 cases.
Conclusion: Surgical repair of PAVC in the first year of life is feasible
with excellent mid-term outcome, even in cases with a small LAVV. Patients
with “parachute like” LAVV may experience significant regurgitation neces-
sitating reoperation.
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